An Athlete’s Battle On and Off the Field: Grace Taylor's story
A Division I lacrosse player at Harvard navigates a life-changing cancer diagnosis with support from the Cancer Center's AYA program.
The CSIBD conducts an Annual Symposium and Workshop focusing on an area of basic investigation relevant to IBD and the research community. This multi-day event hosts internationally renowned speakers, over half of whom travel from outside Boston to present their work to the CSIBD community.
The Symposium is highly effective in providing a forum for Center investigators, especially those receiving support through the Pilot and Feasibility Program, to share their most recent work. The Annual Symposium is coupled with a Workshop, the topics for which are chosen to complement the scientific interests within the CSIBD while simultaneously introducing new areas of interest to explore. Workshops are organized to involve participation of investigators from around the country and abroad in an area of focused discussion and a format that allows extended interaction.
The CSIBD supports seminar series presented by investigators within the Boston area research community as well as from other national and international institutions. In conjunction with their seminar, speakers from outside the Boston area typically spend one to two days at the Center offering the opportunity for investigators and trainees to meet with them to discuss research interests.
Over the past 34 years, CSIBD faculty have held seminars in which young investigators or postdoctoral fellows discuss ongoing IBD- and digestive disease-related research progress. These highly interactive sessions have provided invaluable input to investigators in guiding future work and have stimulated many new collaborations.
Computational biology is a central interface of all aspects of human biology. In response to increasing member interest in utilizing computational approaches to explore broader biological questions, CSIBD leadership and the External Advisory Committee prioritized and introduced new workshops focused on methods in computational biology. Workshops have included an introduction to working in the Google Cloud Platform and on Terra, a cloud-native platform for biomedical analysis, as well as building data-intensive computational pipelines.
The CSIBD Enrichment Program has a history of facilitating the exchange of information between affiliated institutions and beyond through a series of special seminars designed to promote collaboration.
A Division I lacrosse player at Harvard navigates a life-changing cancer diagnosis with support from the Cancer Center's AYA program.
U.S. News & World Report released its “Best Hospitals” for 2024-2025 and Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham health care system, has again earned a spot on the annual Honor Roll. MGH also ranked #1 in the nation in psychiatry.
Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before having weight loss surgery, suggesting that a surgery first strategy could lead to better outcomes.
Myocarditis is driven by a different immune response than the anti-tumor one, suggesting that the serious complication could one day be managed without halting cancer therapy.
Read how proton therapy saved the life of 19-year-old Chris Kobos after he was diagnosed with a rare chordoma.
MGH neighbor and West End staple, The West End Museum, is once again open to the public this summer after being closed for more than two years because of a burst pipe. The newly renovated and reimagined space formally reopened in May.
A Division I lacrosse player at Harvard navigates a life-changing cancer diagnosis with support from the Cancer Center's AYA program.
U.S. News & World Report released its “Best Hospitals” for 2024-2025 and Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham health care system, has again earned a spot on the annual Honor Roll. MGH also ranked #1 in the nation in psychiatry.
Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before having weight loss surgery, suggesting that a surgery first strategy could lead to better outcomes.
Myocarditis is driven by a different immune response than the anti-tumor one, suggesting that the serious complication could one day be managed without halting cancer therapy.